HAVCR2 and glioblastoma: Goods and coworkers [171] analyzed glioblastoma tissues and reported a clear infiltration of PD-1+TIM-3+ lymphocytes that expressed several markers of exhaustion, thus suggesting the therapeutic use of antibodies blocking these two immune checkpoints.